Malats N - Search Results

1

Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological features.

Font A, Domenech M, Ramirez JL, Marqués M, Benítez R, Ruiz de Porras V, Gago JL, Carrato C, Sant F, Lopez H, Castellano D, Malats N, Calle ML, Real FX. Font A, et al. Among authors: malats n. Front Oncol. 2023 Aug 3;13:1155244. doi: 10.3389/fonc.2023.1155244. eCollection 2023. Front Oncol. 2023. PMID: 37588099 Free PMC article.

2

Ki-ras mutations as a prognostic factor in extrahepatic bile system cancer. PANK-ras I Project Investigators.

Malats N, Porta M, Piñol JL, Corominas JM, Rifà J, Real FX. Malats N, et al. J Clin Oncol. 1995 Jul;13(7):1679-86. doi: 10.1200/JCO.1995.13.7.1679. J Clin Oncol. 1995. PMID: 7602358

3

Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I Project Investigations.

Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX. Porta M, et al. Among authors: malats n. J Clin Epidemiol. 1994 Sep;47(9):1069-79. doi: 10.1016/0895-4356(94)90123-6. J Clin Epidemiol. 1994. PMID: 7730910

4

DDT and pancreatic cancer.

Malats N, Real FX, Porta M. Malats N, et al. J Natl Cancer Inst. 1993 Feb 17;85(4):328-9. doi: 10.1093/jnci/85.4.328. J Natl Cancer Inst. 1993. PMID: 8426376 No abstract available.

5

Ki-ras mutations in exocrine pancreatic cancer: association with clinico-pathological characteristics and with tobacco and alcohol consumption. PANK-ras I Project Investigators.

Malats N, Porta M, Corominas JM, Piñol JL, Rifà J, Real FX. Malats N, et al. Int J Cancer. 1997 Mar 17;70(6):661-7. doi: 10.1002/(sici)1097-0215(19970317)70:6<661::aid-ijc6>3.0.co;2-t. Int J Cancer. 1997. PMID: 9096646

6

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

Graus F, Dalmou J, Reñé R, Tora M, Malats N, Verschuuren JJ, Cardenal F, Viñolas N, Garcia del Muro J, Vadell C, Mason WP, Rosell R, Posner JB, Real FX. Graus F, et al. Among authors: malats n. J Clin Oncol. 1997 Aug;15(8):2866-72. doi: 10.1200/JCO.1997.15.8.2866. J Clin Oncol. 1997. PMID: 9256130

7

Human cancer, carcinogenic exposures and mutation spectra.

Vineis P, Malats N, Porta M, Real FX. Vineis P, et al. Among authors: malats n. Mutat Res. 1999 Mar;436(2):185-94. Mutat Res. 1999. PMID: 10095140 Review. No abstract available.

8

Correction: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.

Malats N, Real FX. Malats N, et al. N Engl J Med. 1999 May 20;340(20):1592-3. doi: 10.1056/NEJM199905203402014. N Engl J Med. 1999. PMID: 10336360 Free article. No abstract available.

9

Association between coffee drinking and K-ras mutations in exocrine pancreatic cancer. PANKRAS II Study Group.

Porta M, Malats N, Guarner L, Carrato A, Rifà J, Salas A, Corominas JM, Andreu M, Real FX. Porta M, et al. Among authors: malats n. J Epidemiol Community Health. 1999 Nov;53(11):702-9. doi: 10.1136/jech.53.11.702. J Epidemiol Community Health. 1999. PMID: 10656099 Free PMC article.

10

Cystic fibrosis transmembrane regulator (CFTR) DeltaF508 mutation and 5T allele in patients with chronic pancreatitis and exocrine pancreatic cancer. PANKRAS II Study Group.

Malats N, Casals T, Porta M, Guarner L, Estivill X, Real FX. Malats N, et al. Gut. 2001 Jan;48(1):70-4. doi: 10.1136/gut.48.1.70. Gut. 2001. PMID: 11115825 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters